The possible mechanisms of tumor progression via CSF-1/CSF-1R pathway activation.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 25178319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.

  2014influential reference
• Immunology in the clinic review series; focus on cancer: multiple roles for the immune system in oncogene addiction

  2012cited by this paper
• Macrophage Proliferation Is Regulated through CSF-1 Receptor Tyrosines 544, 559, and 807*

  2012cited by this paper
• Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy

  2012cited by this paper
• Skipping of Exons by Premature Termination of Transcription and Alternative Splicing within Intron-5 of the Sheep SCF Gene: A Novel Splice Variant

  2012cited by this paper
• Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patients.

  2012cited by this paper
• Monocyte-to-Macrophage Differentiation

  2012cited by this paper
• Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab

  2012cited by this paper
• Immunology in the clinic review series; focus on cancer: tumour‐associated macrophages: undisputed stars of the inflammatory tumour microenvironment

  2012cited by this paper
• Macrophage Colony Stimulating Factor Regulation by Nuclear Factor Kappa B: A Relevant Pathway in Human Immunodeficiency Virus Type 1 Infected Macrophages

  2012cited by this paper
• Inflammatory Pathways as Promising Targets to Increase Chemotherapy Response in Bladder Cancer

  2012cited by this paper
• Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein–Barr virus BARF1

  2012cited by this paper
• Macrophage Migration and Its Regulation by CSF-1

  2012cited by this paper
• Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling.

  2012cited by this paper
• The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients

  2012cited by this paper
• The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C.

  2011cited by this paper
• Macrophages in the pathogenesis of atherosclerosis.

  2011cited by this paper
• Mutation D816V Alters the Internal Structure and Dynamics of c-KIT Receptor Cytoplasmic Region: Implications for Dimerization and Activation Mechanisms

  2011cited by this paper
• Tumor Cells and Tumor-Associated Macrophages: Secreted Proteins as Potential Targets for Therapy

  2011cited by this paper
• Colony-stimulating factor-1 exerts direct effects on the proliferation and invasiveness of endometrial epithelial cells.

  2011cited by this paper
• Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

  2011cited by this paper
• Macrophage colony-stimulating factor and its receptor signaling augment glycated albumin-induced retinal microglial inflammation in vitro

  2011cited by this paper
• Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils

  2011cited by this paper
• Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.

  2011cited by this paper
• The unholy trinity: inflammation, cytokines, and STAT3 shape the cancer microenvironment.

  2011cited by this paper
• CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.

  2011influential reference
• TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

  2011cited by this paper
• The epithelial-mesenchymal transition (EMT) phenomenon.

  2010cited by this paper
• Nuclear Factor-κB and Tumor-Associated Macrophages

  2010cited by this paper
• Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis

  2010cited by this paper
• Functional overlap but differential expression of CSF‐1 and IL‐34 in their CSF‐1 receptor‐mediated regulation of myeloid cells

  2010cited by this paper
• A CSF-1 Receptor Phosphotyrosine 559 Signaling Pathway Regulates Receptor Ubiquitination and Tyrosine Phosphorylation*

  2010cited by this paper
• NF‐κB as a central regulator of macrophage function in tumors

  2010cited by this paper
• Macrophage diversity enhances tumor progression and metastasis.

  2010cited by this paper
• c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis

  2010cited by this paper
• Akt–RSK–S6 Kinase Signaling Networks Activated by Oncogenic Receptor Tyrosine Kinases

  2010cited by this paper
• Regulation of macrophage function in tumors: the multifaceted role of NF-kappaB.

  2009cited by this paper
• Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability.

  2009cited by this paper
• The Mechanism of CSF-1-induced Wiskott-Aldrich Syndrome Protein Activation in Vivo

  2009cited by this paper
• CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.

  2009cited by this paper
• Role of CSF-1 in progression of epithelial ovarian cancer.

  2009cited by this paper
• Tumorigenesis and Neoplastic Progression Coordinate Expression of Colony-Stimulating Factor-1 and Colony-Stimulating Factor-1-Related Proteins Is Associated with Poor Prognosis in Gynecological and Nongynecological Leiomyosarcoma

  2009cited by this paper
• Trophic macrophages in development and disease

  2009cited by this paper
• CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.

  2009cited by this paper
• Microenvironmental regulation of metastasis

  2009cited by this paper
• M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis

  2009cited by this paper
• Principles of cancer therapy: oncogene and non-oncogene addiction.

  2009cited by this paper
• Cytokines and atherosclerosis: a comprehensive review of studies in mice

  2008cited by this paper
• Colony-stimulating factors in inflammation and autoimmunity

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Deregulated EGFR Signaling during Lung Cancer Progression: Mutations, Amplicons, and Autocrine Loops

  2008cited by this paper
• The Multifunctional Protein Glyceraldehyde-3-Phosphate Dehydrogenase Is Both Regulated and Controls Colony-Stimulating Factor-1 Messenger RNA Stability in Ovarian Cancer

  2008cited by this paper
• Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells.

  2008cited by this paper
• Tumour immunity: effector response to tumour and role of the microenvironment.

  2008cited by this paper
• Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization

  2008cited by this paper
• Structure of macrophage colony stimulating factor bound to FMS: Diverse signaling assemblies of class III receptor tyrosine kinases

  2008cited by this paper
• The prognostic impact of M‐CSF, CSF‐1 receptor, CD68 and CD3 in prostatic carcinoma

  2008cited by this paper
• CSF‐1 receptor structure/function in MacCsf1r–/– macrophages: regulation of proliferation, differentiation, and morphology

  2008cited by this paper
• Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells

  2008cited by this paper
• Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion

  2007cited by this paper
• Can anti‐migratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of cell migration

  2007cited by this paper
• Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines.

  2007cited by this paper
• Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression.

  2007cited by this paper
• High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity

  2007cited by this paper
• Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications.

  2007cited by this paper
• Epidermal growth factor receptor mutations in lung cancer

  2007cited by this paper
• Inflammatory cell infiltration of tumors: Jekyll or Hyde

  2007cited by this paper
• Colony-stimulating factor-1 in immunity and inflammation.

  2006influential reference
• Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.

  2006cited by this paper
• Inflammation and cancer: how hot is the link?

  2006cited by this paper
• Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop.

  2005cited by this paper
• Stem cell factor and macrophage-colony stimulating factor in patients with pancreatic cancer

  2004cited by this paper
• Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture

  2004cited by this paper
• Macrophage Colony-Stimulating Factor as a Tumor Marker for Squamous Cell Carcinoma of the Head and Neck

  2003cited by this paper
• Cytokine profiles in patients receiving wide-field + prostate boost radiotherapy (xRT) for adenocarcinoma of the prostate.

  2003cited by this paper
• Hematopoietic Growth Factors in Colorectal Cancer Patients

  2003cited by this paper
• Accelerated Phagocytosis of Amyloid-β by Mouse and Human Microglia Overexpressing the Macrophage Colony-stimulating Factor Receptor*

  2002cited by this paper
• Molecular mechanism for feedback regulation of C4 biosynthesis in guinea pig peritoneal macrophage

  1984cited by this paper

• Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets

  2025cites this paper
• CSF-1R blockade to alleviate azithromycin mediated immunosuppression in a mouse model of intracellular infection.

  2024cites this paper
• JDF promotes the apoptosis of M2 macrophages and reduces epithelial-mesenchymal transition and migration of liver cancer cells by inhibiting CSF-1/PI3K/AKT signaling pathway

  2024cites this paper
• CSF-1R in Cancer: More than a Myeloid Cell Receptor

  2024cites this paper
• Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.

  2023cites this paper
• A Pilot Cross-Sectional Study of Immunological and Microbiome Profiling Reveals Distinct Inflammatory Profiles for Smokers, Electronic Cigarette Users, and Never-Smokers

  2023cites this paper
• Macrophage subsets and their role: co-relation with colony-stimulating factor-1 receptor and clinical relevance

  2022cites this paper
• Overexpression of macrophage-colony stimulating factor-1 receptor as a prognostic factor for survival in cancer

  2021cites this paper
• Use of a rapid human primary cell-based disease screening model, to compare next generation products to combustible cigarettes

  2021cites this paper
• Fibronectin in Cancer: Friend or Foe

  2019cites this paper
• Increased invasive phenotype of CSF-1R expression in glioma cells via the ERK1/2 signaling pathway

  2018cites this paper
• Inhibition of the CSF‐1 receptor sensitizes ovarian cancer cells to cisplatin

  2018cites this paper
• Stromal contributions to the carcinogenic process

  2017cites this paper
• Emerging role of immunotherapy in urothelial carcinoma-Future directions and novel therapies.

  2016cites this paper